Two of the biggest pharmaceutical companies are joining forces in a blockbuster merger. Bristol-Myers Squibb is buying Celgene in a cash and stock deal valued at about $74 billion.

On Sunday, February 24, film fans, pop culture fanatics, and all of Hollywood’s brightest stars will tune in to the live broadcast of the 91st Oscars ceremony. With eight movies nominated for best picture, from the bombastic Queen biopic Bohemian Rhapsody to the devastatingly poetic Roma, the ceremony is guaranteed to be star-studded, ornate, and maybe even a little unpredictable.

As more and more of our daily life becomes automated, analyzed, and interconnected, people look forward to the Consumer Electronics Show (CES) every year to learn about emerging tech and its potential application to everyday life.

If you were following patent and innovation news in 2018, it was hard to avoid mentions of 3D printing.

Data-driven decisions can help shape a more successful patent prosecution and business development strategy, but navigating the complex data isn’t always an easy task.

With the "Table View" in Juristat Platform, you can organize application reports by selecting from more than 125 different data points.

Watch our latest video to learn how to extract informative data sets to improve your patent prosecution process. 

IBM recently took a giant step forward to position itself as a leader in the new frontier of cloud computing.

As patent lawyers working with creators and innovators, you rely on complex data and historical trends to make informed decisions in your patent prosecutions.

Juristat organizes and visualizes big data to help patent prosecutors identify the most advantageous responses to office actions while providing clients with unparalleled transparency into the decision-making process.

Watch our latest video to learn how to access useful examiner data that can inform your patent prosecution:

All companies applying for patents need to stay up to date on competitor activity that may threaten the viability of their patent applications.

Juristat Platform consolidates Public PAIR information to help companies identify and monitor pending competitor applications for new developments.

Learn how to narrow your search to competitor applications in relevant tech areas and create a saved filter to regularly return for future review.

With 15 consecutive years on the Fortune 500 list, Monsanto has had a huge impact on innovation in modern farming and biotech. As a patent analytics company, we were curious to see how Bayer's recent acquisition of Monsanto impacts their IP portfolio.

Last week, we identified the ten Most Difficult Examiners currently reviewing applications at the USPTO. By understanding how an examiner has performed in the past, patent professionals can manage client expectations and structure a prosecution strategy that maximizes an application’s likelihood of allowance. Through Juristat’s Examiner Reports, you can dive deeper into the decision-making mindset of each Examiner by seeing his or her typical prosecution process from application to disposition.